Immix Biopharma, Inc.
Recent Filings
All 212 filings →| Form | Description | Date |
|---|---|---|
| 10-K/A | 10-K/A | Mar 27, 2026 |
| S-8 | S-8 | Mar 25, 2026 |
| 8-K | 8-K | Mar 25, 2026 |
| 424B5 | 424B5 | Mar 25, 2026 |
| 10-K | 10-K | Mar 25, 2026 |
| SCHEDULE 13G | — | Mar 20, 2026 |
| SCHEDULE 13G | — | Feb 17, 2026 |
| EFFECT | — | Jan 22, 2026 |
| CORRESP | — | Jan 16, 2026 |
| UPLOAD | — | Jan 16, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Rachman Ilya M | CEO and Chairman | Purchase | 746 @ $6.67 | 1,141,683 | Dec 10, 2025 |
| Rachman Ilya M | CEO and Chairman | Purchase | 2,500 @ $2.02 | 1,140,937 | Sep 17, 2025 |
| Morris Gabriel S | CFO | Purchase | 2,600 @ $1.97 | 290,659 | Sep 16, 2025 |
| Rachman Ilya M | CEO and Chairman | Purchase | 2,178 @ $2.30 | 1,138,437 | Jun 18, 2025 |
| Morris Gabriel S | CFO | Purchase | 2,225 @ $2.28 | 288,059 | Jun 18, 2025 |
| Hsu Jason | — | Purchase | 7,700 @ $2.17 | 853,000 | Dec 23, 2024 |
| Hsu Jason | — | Purchase | 8,100 @ $2.25 | 845,300 | Aug 21, 2024 |
| Ng Carey | — | Purchase | 10,000 @ $1.86 | 20,000 | Aug 16, 2024 |
| Hsu Jason | — | Purchase | 3,200 @ $2.07 | 816,200 | Jul 24, 2024 |
| Rachman Ilya M | CEO and Chairman | Purchase | 2,600 @ $2.13 | 1,136,259 | Jun 7, 2024 |